Chimagan
All
Newsflash
Article
-
British pharmaceutical giant GSK licenses cancer drug from China's Chimagen Biosciences in deal worth up to $750 million
GSK announced plans on Tuesday to acquire full global rights to a T-cell engager (TCE) from Chengdu-based Chimagen, targeting treatment for multiple myeloma, a type of blood cancer.
-
British pharmaceutical giant GSK licenses cancer drug from China's Chimagen Biosciences in deal worth up to $750 million
GSK announced plans on Tuesday to acquire full global rights to a T-cell engager (TCE) from Chengdu-based Chimagen, targeting treatment for multiple myeloma, a type of blood cancer.
- No data
Chimagan
Svmuu provides news and information related to Chimagan, as well as real-time data on Chimagan. We provide in-depth analysis and interpretation of the latest Chimagan developments, helping investors stay informed about Chimagan policy updates. Svmuu is your essential tool for keeping up with the latest Chimagan trends! Here, we’ll join you in keeping a close eye on Chimagan news and use a clear macro perspective to make sense of the uncertain future of crypto.
24H Trending
-
1
Coinbase is down 14.04% from its previous close, now trading at $138.050.
-
2
Coinbase leads sell-off in crypto-related stocks after Binance's $6.3 billion hack, with Circle and Strategy shares plummeting.
-
3
Gold prices fell to $3,883.36, hitting a near 365-day low.
-
4
NVIDIA is down 5.17% from its previous close, now trading at $202.620.
-
5
Coinbase is down 12.49% from its previous close, now trading at $140.540.
-
6
An Analysis of Potential Issues in the Operation of China's Digital Yuan
-
7
Gold is down 3.45% from its previous close, now trading at $3,883.36.
-
8
Chainalysis: Binance Hackers Deployed Unprecedented Money Laundering Tactics, Rapidly Converting $6.3 Billion in Stolen Funds
-
9
SuperVerse (SUPER) Issuance and Circulation: Total Supply, Unlocking, and Deflationary Mechanisms Explained
-
10
What is ELTCOIN? Project Positioning and Market Status
Markets Today
Recommended Reading


